Suppr超能文献

CXCL 基因在透明细胞肾细胞癌中的预后意义及机制。

Prognostic significance and mechanisms of CXCL genes in clear cell renal cell carcinoma.

机构信息

The Department of Urology, The First Affiliated Hospital of Huzhou Normal College, Huzhou, Zhejiang 31300, China.

Huzhou Key Laboratory of Precise Diagnosis and Treatment of Urinary Tumors, Huzhou, Zhejiang 31300, China.

出版信息

Aging (Albany NY). 2023 Aug 3;15(16):7974-7996. doi: 10.18632/aging.204922.

Abstract

This study aimed to investigate the clinical significance, biological functions, and underlying mechanisms of CXCL genes in clear cell renal cell carcinoma (ccRcc) based on patient datasets and pan-cancer analysis. The interaction between CXCL genes in ccRcc and immune components, particularly in relation to neutrophil recruitment and polarization mechanisms, was also evaluated. Furthermore, a risk score was developed using a signature for neutrophil polarization. The role of CXCL2 was assessed through experiments. Results showed that five CXCL genes (CXCL 2, 5, 9, 10, and 11) were upregulated in renal cancer tissue, while seven genes (CXCL 1, 2, 3, 5, 8, 13, and 14) significantly impacted patient survival. Moreover, CXCL 1, 5, and 13 affected progression-free survival. Besides, differences in mRNA expression and immune components affected renal cancer outcomes. Furthermore, three pairs of CXCL gene-immune cell interactions (CXCL13-CD8+ T cells, CXCL9/10-M1 cells, CXCL1/2/3/8-neutrophils) were identified through single-cell and pan-cancer analysis. A TAN risk score with prognostic value for KIRC patients was constructed using 11 genes and a TAN signature. Neutrophil polarization significantly impacted survival. Notably, CXCL2 was involved in neutrophil recruitment and polarization, thus promoting ccRcc progression. In conclusion, seven prognostic CXCL genes (CXCL 1/2/3/5/8/13/14) for ccRcc patients and three pairs of CXCL gene-immune cell interactions were identified. Furthermore, results showed that CXCL 2 promotes ccRcc progression through neutrophil recruitment and polarization.

摘要

本研究旨在基于患者数据集和泛癌症分析,探讨 CXCL 基因在透明细胞肾细胞癌(ccRcc)中的临床意义、生物学功能和潜在机制。还评估了 CXCL 基因在 ccRcc 中与免疫成分的相互作用,特别是与中性粒细胞募集和极化机制的关系。此外,还使用中性粒细胞极化特征开发了风险评分。通过实验评估了 CXCL2 的作用。结果表明,五种 CXCL 基因(CXCL2、5、9、10 和 11)在肾癌组织中上调,而七种基因(CXCL1、2、3、5、8、13 和 14)显著影响患者生存。此外,CXCL1、5 和 13 影响无进展生存期。此外,mRNA 表达和免疫成分的差异影响肾癌结局。此外,通过单细胞和泛癌症分析鉴定了三对 CXCL 基因-免疫细胞相互作用(CXCL13-CD8+T 细胞、CXCL9/10-M1 细胞、CXCL1/2/3/8-中性粒细胞)。使用 11 个基因和 TAN 特征构建了具有 KIRC 患者预后价值的 TAN 风险评分。中性粒细胞极化对生存有显著影响。值得注意的是,CXCL2 参与中性粒细胞募集和极化,从而促进 ccRcc 进展。总之,鉴定了 7 个与 ccRcc 患者预后相关的预后 CXCL 基因(CXCL1/2/3/5/8/13/14)和 3 对 CXCL 基因-免疫细胞相互作用。此外,结果表明,CXCL2 通过中性粒细胞募集和极化促进 ccRcc 进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd5/10497021/d74f593c35e4/aging-15-204922-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验